1. |
Hospitalisation a surrogate for cost and burden of therapy |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
2. |
Ceftriaxone - a better deal than older cephalosporins |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 3-4
Pamela Hunter,
Preview
|
|
摘要:
Ceftriaxone is a third-generation injectable cephalosporin. Like other third-generation cephalosporins, it has a broad spectrum of activity against bacterial species, including Gram-positive and Gram-negative bacteria, and is also stable against a wide range of β-lactamases. Like many third-generation cephalosporins, ceftriaxone is more expensive than earlier cephalosporins, but its long serum half-life (approximately 6-8 hours) means that it can be administered once daily, which can lead to cost savings. At the 11th European Congress of Clinical Microbiology and Infectious Diseases [Istanbul, Turkey; April 2001], 2 poster presentations showed that ceftriaxone once daily was more effective than less costly agents, and as effective as newer, more expensive agents, in the treatment of secondary peritonitis and biliary tract infections.1, 2
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
3. |
Improved health in US elderly due to Medicare? |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
4. |
News in brief ... |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
5. |
News in brief ... |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
6. |
News in brief ... |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
7. |
Asthma is costly for MCOs |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
8. |
Extra cost of abciximab justified in PCI? |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
9. |
Temozolomide improves QOL in anaplastic astrocytoma |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 10-11
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|
10. |
News in brief ... |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 313,
2001,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2001
数据来源: ADIS
|